²úÆ·¹©Ó¦Íײ¼Ã¹ËØ

  • ·¢²¼ÈÕÆÚ£º2024-05-07
  • ÓÐЧÆÚÏÞ£º30Ìì
ºþ±±ºãÂÌÔ´¿Æ¼¼ÓÐÏÞ¹«Ë¾ VIP
251-322-5
C20H41N5O7
463.5688

ÏêϸÐÅÏ¢
  • ;Íв¼Ã¹ËØ;Íײ¼À­Ã¹ËØ;ÍÐÆÕùËØ;
  • tobramycin
  • ;Tobramycin, Free Base;Tobramycin Base;(1S,2S,3R,4S,6R)-4,6-diamino-3-[(2,6-diamino-2,3,6-trideoxy-alpha-D-ribo-hexopyranosyl)oxy]-2-hydroxycyclohexyl 3-amino-3-deoxy-alpha-D-glucopyranoside;4-amino-2-[4,6-diamino-3-[[2-amino-5-(aminomethyl)-4-hydroxy-cyclohexyl]methyl]-2-hydroxy-cyclohexoxy]-6-(hydroxymethyl)tetrahydropyran-3,5-diol;
  • InChI=1/C20H41N5O7/c21-5-8-1-7(10(22)4-13(8)27)2-9-11(23)3-12(24)19(16(9)28)32-20-18(30)15(25)17(29)14(6-26)31-20/h7-20,26-30H,1-6,21-25H2
  • 1.42g/cm3
  • 741.6¡ãC at 760 mmHg
  • 402.3¡ãC

ÃâÔðÉùÃ÷£ºÒÔÉÏËùչʾµÄÐÅÏ¢ÓÉÆóÒµ×ÔÐÐÌṩ£¬ÄÚÈݵÄÕæʵÐÔ¡¢×¼È·ÐԺͺϷ¨ÐÔÓÉ·¢²¼ÆóÒµ¸ºÔ𣬻¯¹¤Íø¶Ô´Ë²»³Ðµ£Èκα£Ö¤ÔðÈΡ£ÎÒÃÇÔ­ÔòÉϽ¨ÒéÄúÑ¡Ôñ»¯¹¤Íø¸ß¼¶»áÔ±»òVIP»áÔ±¡£